Printer Friendly

BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR SECOND QUARTER

 BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES
 AND EARNINGS FOR SECOND QUARTER
 WATERTOWN, Mass., July 28 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today released results for its second quarter ended June 30, 1992.
 Net sales for the second quarter increased 37 percent to $76,327,000 from the previous year's $55,855,000. Net earnings for the quarter were $13,305,000 or 14 cents per share, compared to $10,767,000 or 11 cents per share in the previous year. Net sales for the first half of 1992 increased 40 percent to $148,951,000 compared to $106,339,000 for the same period last year. Net earnings for the first half increased 28 percent to $25,840,000 or 27 cents per share, compared to $20,265,000 or 21 cents per share in the previous year.
 Pete Nicholas, co-chairman and chief executive officer said, "Business across all of the company's divisions continue to show strong growth in net sales and earnings. New products have contributed significantly to the results of the second quarter and first half of 1992. We expect this trend to continue for the remainder of 1992 and into 1993."
 Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices. The company sells over 3,000 products in more than 40 major categories which are used by physicians to perform less invasive medical procedures. The company's products are used in a broad range of interventional medical specialties, including cardiology, gastroenterology, pulmonary medicine, radiology, urology and vascular surgery.
 BOSTON SCIENTIFIC CORPORATION
 (in millions, except per share amounts)
 Three Months Ended Six Months Ended
 (Unaudited) June 30 June 30
 1992 1991 1992 1991
 Net sales $76,327 $55,855 $148,951 $106,339
 Cost of products sold 28,260 19,311 54,886 36,114
 Gross Profit 48,067 36,544 94,065 70,225
 Selling, general and
 administrative expenses 21,710 15,807 42,771 30,484
 Research & development
 expenses 4,392 2,638 8,201 5,252
 Total 26,102 18,445 50,972 35,736
 Income from operations 21,965 18,099 43,093 34,489
 Other income (expense)
 Other income 431 146 654 269
 Interest expense (801) (764) (1,503) (1,661)
 Other expenses (238) 26 (279) (146)
 Income before income taxes
 and extraordinary credit 21,357 17,507 41,965 32,951
 Income taxes 8,052 6,805 16,125 12,808
 Income before
 extraordinary credit 13,305 10,702 25,840 20,143
 Extraordinary income tax
 credit from utilization
 of NOL carryforwards --- 65 --- 122
 Net income $13,305 $10,767 $25,840 $20,265
 Net income per share 14 cents 11 cents 27 cents 21 cents
 Weighted average
 number of shares 97,182,970 94,148,575 95,665,772 94,148,575
 -0- 7/28/92
 /CONTACT: Larry Best, Boston Scientific Corporation, 617-972-4450/
 (BSX) CO: Boston Scientific Corporation ST: Massachusetts IN: MTC SU: ERN


CH -- NE003 -- 3913 07/28/92 09:30 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 28, 1992
Words:495
Previous Article:MESA MEDICAL REPORTS INCREASED FIRST QUARTER SALES AND EARNINGS
Next Article:CHRYSLER REPORTS SECOND-QUARTER RESULTS
Topics:


Related Articles
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER
BOSTON SCIENTIFIC CORPORATION REPORTS CONTINUED GROWTH IN SALES AND EARNINGS FOR YEAR ENDED DECEMBER 31, 1992
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR FIRST QUARTER
BOSTON SCIENTIFIC CORPORATION REPORTS INCREASED SALES AND EARNINGS FOR THIRD QUARTER
BOSTON SCIENTIFIC CORPORATION ADDRESSES SECOND QUARTER REVENUE GROWTH
BOSTON SCIENTIFIC CORPORATION ADDRESSES SECOND QUARTER REVENUE GROWTH
BOSTON SCIENTIFIC CORPORATION ANNOUNCES RESULTS FOR SECOND QUARTER
Boston Scientific Corporation Addresses Third Quarter Growth
Boston Scientific Corporation Announces Second Quarter Results
Boston Scientific Corporation Announces Second Quarter Results

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters